This home health services provider has seen a flat track record when it comes to current year estimate revisions, as there has been only one negative revision in the past few weeks. The consensus for earnings estimate hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
GTIV currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Investors interested in the Medical output/Home care industry may consider better-ranked stocks like Almost Family Inc. (AFAM), Chemed Corp. (CHE) and China Cord Blood Corporation (CO). While Almost Family and Chemed carry a Zacks Rank #1 (Strong Buy), China Cord holds a Zacks rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Be the first to comment